1. ↑ Jump up to:1.0 1.1 1.2 1.3 Aneja S. Evaluation of a child with cerebral palsy. The Indian Journal of Pediatrics. 2004 Jul;71(7):627-34.
  2. ↑ Jump up to:2.0 2.1 2.2 Brehm M, Bus SA, Harlaar J, Nollet F. A candidate core set of outcome measures based on the international classification of functioning, disability and health for clinical studies on lower limb orthoses. Prosthetics and orthotics international. 2011 Sep;35(3):269-77.
  3. ↑ Jump up to:3.0 3.1 3.2 3.3 Lance JW. Spasticity: Disordered Motor Control. Feldman RG, Young R.R., Koella W.P. , editor. Chicago: Year Book Medical Publishers; 1980.
  4. ↑ Jump up to:4.0 4.1 4.2 4.3 4.4 4.5 4.6 Scholtes VA, Becher JG, Beelen A, Lankhorst GJ. Clinical assessment of spasticity in children with cerebral palsy: a critical review of available instruments. Developmental Medicine & Child Neurology. 2006 Jan;48(1):64-73.
  5. ↑ Jump up to:5.0 5.1 5.2 5.3 5.4 Love SC, Novak I, Kentish M, Desloovere K, Heinen F, Molenaers G, O’flaherty S, Graham HK. Botulinum toxin assessment, intervention and after‐care for lower limb spasticity in children with cerebral palsy: international consensus statement. European Journal of Neurology. 2010 Aug;17:9-37.
  6. ↑ Jump up to:6.0 6.1 6.2 6.3 6.4 6.5 6.6 6.7 Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. European Journal of Neurology. 1999 Nov;6:s23-35.
  7. ↑ Jump up to:7.0 7.1 7.2 Boyd RN, Barwood SA, Baillieu CE, Graham HK. Validity of a clinical measure of spasticity in children with cerebral palsy in a randomized clinical trial. Dev Med Child Neurol. 1998 Aug;40(Suppl 78):7.
  8. ↑ Jump up to:8.0 8.1 8.2 8.3 8.4 8.5 Fosang AL, Galea MP, McCoy AT, Reddihough DS, Story I. Measures of muscle and joint performance in the lower limb of children with cerebral palsy. Developmental medicine and child neurology. 2003 Oct;45(10):664-70.
  9. ↑ Jump up to:9.0 9.1 Graham HK, Aoki KR, Autti-Rämö I, Boyd RN, Delgado MR, Gaebler-Spira DJ, Gormley Jr ME, Guyer BM, Heinen F, Holton AF, Matthews D. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait & posture. 2000 Feb 1;11(1):67-79.
  10. ↑ Jump up to:10.0 10.1 Rw B, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys ther. 1987;67(2):206-7.